Quidel reported $618.9M in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Abbott USD 13.01B 423M Sep/2026
Agilent USD 1.88B 43M Jun/2026
Becton, Dickinson and Co. USD 5.3B 300M Sep/2026
Bruker USD 874M 35.5M Sep/2026
Cerus USD 50.81M 4.79M Dec/2024
Charles River Laboratories USD 982.7M 17.3M Sep/2026
Danaher USD 6.55B 254M Sep/2026
Haemonetics USD 357.76M 18.76M Sep/2026
Illumina USD 1.17B 10M Sep/2026
IQVIA Holdings USD 4.43B 60M Sep/2026
Merit Medical Systems USD 416.24M 2.56M Sep/2026
Mettler Toledo International USD 1.09B 60M Sep/2026
Myriad Genetics USD 190.7M 9.7M Jun/2026
Neogen USD 222.8M 2.5M Jun/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Quidel USD 618.9M 12M Sep/2026
Revvity USD 729M 680K Sep/2026
STAAR Surgical USD 83.4M 10.1M Sep/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
Waters USD 1.77B 130M Sep/2026